Global Targeted Radiopharmaceuticals Supply, Demand and Key Producers, 2023-2029
The global Targeted Radiopharmaceuticals market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
The radiopharmaceuticals market had been experiencing steady growth and significant interest due to the increasing use of nuclear medicine procedures for diagnostic and therapeutic purposes. Radiopharmaceuticals are essential tools in nuclear medicine, and they play a crucial role in diagnosing various diseases, such as cancer, cardiovascular conditions, and neurological disorders.
The radiopharmaceuticals market had been growing steadily over the years. Factors contributing to this growth include advancements in radiopharmaceutical development, rising prevalence of cancer and cardiovascular diseases, and an aging population that drives the demand for diagnostic procedures.
Targeted radiopharmaceuticals are a type of medicinal product that combines a biologically active molecule (known as a ligand or targeting agent) with a radioactive isotope (radionuclide). These radiopharmaceuticals are designed to deliver radiation specifically to certain cells, tissues, or organs in the body, with the goal of achieving precise and localized treatment or imaging.
The concept of targeted radiopharmaceuticals is based on the idea of using the biological specificity of the ligand to selectively bind to receptors or antigens present on the target cells. Once the ligand has bound to its target, the radioactive component emits radiation that can be used for therapeutic purposes or imaging.There are two main categories of targeted radiopharmaceuticals: targeted therapeutic radiopharmaceuticals and targeted diagnostic radiopharmaceuticals.
Targeted radiopharmaceuticals offer several advantages over traditional treatments or imaging agents, including increased specificity, reduced damage to healthy tissues, and the potential for personalized medicine approaches based on the patient's specific disease characteristics. However, the development and use of targeted radiopharmaceuticals require careful consideration of the ligand's biological properties, radionuclide characteristics, and safety profiles to ensure effective and safe medical applications.
This report studies the global Targeted Radiopharmaceuticals production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Targeted Radiopharmaceuticals, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Targeted Radiopharmaceuticals that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Targeted Radiopharmaceuticals total production and demand, 2018-2029, (K Units)
Global Targeted Radiopharmaceuticals total production value, 2018-2029, (USD Million)
Global Targeted Radiopharmaceuticals production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Targeted Radiopharmaceuticals consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Targeted Radiopharmaceuticals domestic production, consumption, key domestic manufacturers and share
Global Targeted Radiopharmaceuticals production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Targeted Radiopharmaceuticals production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Targeted Radiopharmaceuticals production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Targeted Radiopharmaceuticals market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Bayer, Lantheus, Institute for Radioelements (IRE), Radiomedix, Curium Pharma, Clarity Pharmaceuticals, ROTOP and Ratio Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Targeted Radiopharmaceuticals market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Targeted Radiopharmaceuticals Market, By Region:
1. How big is the global Targeted Radiopharmaceuticals market?
2. What is the demand of the global Targeted Radiopharmaceuticals market?
3. What is the year over year growth of the global Targeted Radiopharmaceuticals market?
4. What is the production and production value of the global Targeted Radiopharmaceuticals market?
5. Who are the key producers in the global Targeted Radiopharmaceuticals market?
6. What are the growth factors driving the market demand?
The radiopharmaceuticals market had been experiencing steady growth and significant interest due to the increasing use of nuclear medicine procedures for diagnostic and therapeutic purposes. Radiopharmaceuticals are essential tools in nuclear medicine, and they play a crucial role in diagnosing various diseases, such as cancer, cardiovascular conditions, and neurological disorders.
The radiopharmaceuticals market had been growing steadily over the years. Factors contributing to this growth include advancements in radiopharmaceutical development, rising prevalence of cancer and cardiovascular diseases, and an aging population that drives the demand for diagnostic procedures.
Targeted radiopharmaceuticals are a type of medicinal product that combines a biologically active molecule (known as a ligand or targeting agent) with a radioactive isotope (radionuclide). These radiopharmaceuticals are designed to deliver radiation specifically to certain cells, tissues, or organs in the body, with the goal of achieving precise and localized treatment or imaging.
The concept of targeted radiopharmaceuticals is based on the idea of using the biological specificity of the ligand to selectively bind to receptors or antigens present on the target cells. Once the ligand has bound to its target, the radioactive component emits radiation that can be used for therapeutic purposes or imaging.There are two main categories of targeted radiopharmaceuticals: targeted therapeutic radiopharmaceuticals and targeted diagnostic radiopharmaceuticals.
Targeted radiopharmaceuticals offer several advantages over traditional treatments or imaging agents, including increased specificity, reduced damage to healthy tissues, and the potential for personalized medicine approaches based on the patient's specific disease characteristics. However, the development and use of targeted radiopharmaceuticals require careful consideration of the ligand's biological properties, radionuclide characteristics, and safety profiles to ensure effective and safe medical applications.
This report studies the global Targeted Radiopharmaceuticals production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Targeted Radiopharmaceuticals, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Targeted Radiopharmaceuticals that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Targeted Radiopharmaceuticals total production and demand, 2018-2029, (K Units)
Global Targeted Radiopharmaceuticals total production value, 2018-2029, (USD Million)
Global Targeted Radiopharmaceuticals production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Targeted Radiopharmaceuticals consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Targeted Radiopharmaceuticals domestic production, consumption, key domestic manufacturers and share
Global Targeted Radiopharmaceuticals production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Targeted Radiopharmaceuticals production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Targeted Radiopharmaceuticals production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Targeted Radiopharmaceuticals market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Bayer, Lantheus, Institute for Radioelements (IRE), Radiomedix, Curium Pharma, Clarity Pharmaceuticals, ROTOP and Ratio Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Targeted Radiopharmaceuticals market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Targeted Radiopharmaceuticals Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Targeted Therapeutic Radiopharmaceuticals
- Targeted Diagnostic Radiopharmaceuticals
- Targeted Therapy
- Targeted Diagnosis
- Novartis
- Bayer
- Lantheus
- Institute for Radioelements (IRE)
- Radiomedix
- Curium Pharma
- Clarity Pharmaceuticals
- ROTOP
- Ratio Therapeutics
- Fusion Pharmaceuticals
- Perspective Therapeutics
- RayzeBio
- Alpha-9 Theranostics
- Radiopharm Theranostics
- Telix Pharmaceuticals
- Ariceum Therapeutics
- Aktis Oncology
- Navidea Biopharmaceuticals
- Nucleus RadioPharma
- SmartNuclide Biopharma
- TetraKit Technologies
1. How big is the global Targeted Radiopharmaceuticals market?
2. What is the demand of the global Targeted Radiopharmaceuticals market?
3. What is the year over year growth of the global Targeted Radiopharmaceuticals market?
4. What is the production and production value of the global Targeted Radiopharmaceuticals market?
5. Who are the key producers in the global Targeted Radiopharmaceuticals market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Targeted Radiopharmaceuticals Introduction
1.2 World Targeted Radiopharmaceuticals Supply & Forecast
1.2.1 World Targeted Radiopharmaceuticals Production Value (2018 & 2022 & 2029)
1.2.2 World Targeted Radiopharmaceuticals Production (2018-2029)
1.2.3 World Targeted Radiopharmaceuticals Pricing Trends (2018-2029)
1.3 World Targeted Radiopharmaceuticals Production by Region (Based on Production Site)
1.3.1 World Targeted Radiopharmaceuticals Production Value by Region (2018-2029)
1.3.2 World Targeted Radiopharmaceuticals Production by Region (2018-2029)
1.3.3 World Targeted Radiopharmaceuticals Average Price by Region (2018-2029)
1.3.4 North America Targeted Radiopharmaceuticals Production (2018-2029)
1.3.5 Europe Targeted Radiopharmaceuticals Production (2018-2029)
1.3.6 China Targeted Radiopharmaceuticals Production (2018-2029)
1.3.7 Japan Targeted Radiopharmaceuticals Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Targeted Radiopharmaceuticals Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Targeted Radiopharmaceuticals Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Targeted Radiopharmaceuticals Demand (2018-2029)
2.2 World Targeted Radiopharmaceuticals Consumption by Region
2.2.1 World Targeted Radiopharmaceuticals Consumption by Region (2018-2023)
2.2.2 World Targeted Radiopharmaceuticals Consumption Forecast by Region (2024-2029)
2.3 United States Targeted Radiopharmaceuticals Consumption (2018-2029)
2.4 China Targeted Radiopharmaceuticals Consumption (2018-2029)
2.5 Europe Targeted Radiopharmaceuticals Consumption (2018-2029)
2.6 Japan Targeted Radiopharmaceuticals Consumption (2018-2029)
2.7 South Korea Targeted Radiopharmaceuticals Consumption (2018-2029)
2.8 ASEAN Targeted Radiopharmaceuticals Consumption (2018-2029)
2.9 India Targeted Radiopharmaceuticals Consumption (2018-2029)
3 WORLD TARGETED RADIOPHARMACEUTICALS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Targeted Radiopharmaceuticals Production Value by Manufacturer (2018-2023)
3.2 World Targeted Radiopharmaceuticals Production by Manufacturer (2018-2023)
3.3 World Targeted Radiopharmaceuticals Average Price by Manufacturer (2018-2023)
3.4 Targeted Radiopharmaceuticals Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Targeted Radiopharmaceuticals Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Targeted Radiopharmaceuticals in 2022
3.5.3 Global Concentration Ratios (CR8) for Targeted Radiopharmaceuticals in 2022
3.6 Targeted Radiopharmaceuticals Market: Overall Company Footprint Analysis
3.6.1 Targeted Radiopharmaceuticals Market: Region Footprint
3.6.2 Targeted Radiopharmaceuticals Market: Company Product Type Footprint
3.6.3 Targeted Radiopharmaceuticals Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Targeted Radiopharmaceuticals Production Value Comparison
4.1.1 United States VS China: Targeted Radiopharmaceuticals Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Targeted Radiopharmaceuticals Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Targeted Radiopharmaceuticals Production Comparison
4.2.1 United States VS China: Targeted Radiopharmaceuticals Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Targeted Radiopharmaceuticals Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Targeted Radiopharmaceuticals Consumption Comparison
4.3.1 United States VS China: Targeted Radiopharmaceuticals Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Targeted Radiopharmaceuticals Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Targeted Radiopharmaceuticals Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Targeted Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Targeted Radiopharmaceuticals Production Value (2018-2023)
4.4.3 United States Based Manufacturers Targeted Radiopharmaceuticals Production (2018-2023)
4.5 China Based Targeted Radiopharmaceuticals Manufacturers and Market Share
4.5.1 China Based Targeted Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Targeted Radiopharmaceuticals Production Value (2018-2023)
4.5.3 China Based Manufacturers Targeted Radiopharmaceuticals Production (2018-2023)
4.6 Rest of World Based Targeted Radiopharmaceuticals Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Targeted Radiopharmaceuticals Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Targeted Radiopharmaceuticals Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Targeted Radiopharmaceuticals Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Targeted Radiopharmaceuticals Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Targeted Therapeutic Radiopharmaceuticals
5.2.2 Targeted Diagnostic Radiopharmaceuticals
5.3 Market Segment by Type
5.3.1 World Targeted Radiopharmaceuticals Production by Type (2018-2029)
5.3.2 World Targeted Radiopharmaceuticals Production Value by Type (2018-2029)
5.3.3 World Targeted Radiopharmaceuticals Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Targeted Radiopharmaceuticals Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Targeted Therapy
6.2.2 Targeted Diagnosis
6.3 Market Segment by Application
6.3.1 World Targeted Radiopharmaceuticals Production by Application (2018-2029)
6.3.2 World Targeted Radiopharmaceuticals Production Value by Application (2018-2029)
6.3.3 World Targeted Radiopharmaceuticals Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Targeted Radiopharmaceuticals Product and Services
7.1.4 Novartis Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Bayer
7.2.1 Bayer Details
7.2.2 Bayer Major Business
7.2.3 Bayer Targeted Radiopharmaceuticals Product and Services
7.2.4 Bayer Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bayer Recent Developments/Updates
7.2.6 Bayer Competitive Strengths & Weaknesses
7.3 Lantheus
7.3.1 Lantheus Details
7.3.2 Lantheus Major Business
7.3.3 Lantheus Targeted Radiopharmaceuticals Product and Services
7.3.4 Lantheus Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Lantheus Recent Developments/Updates
7.3.6 Lantheus Competitive Strengths & Weaknesses
7.4 Institute for Radioelements (IRE)
7.4.1 Institute for Radioelements (IRE) Details
7.4.2 Institute for Radioelements (IRE) Major Business
7.4.3 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product and Services
7.4.4 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Institute for Radioelements (IRE) Recent Developments/Updates
7.4.6 Institute for Radioelements (IRE) Competitive Strengths & Weaknesses
7.5 Radiomedix
7.5.1 Radiomedix Details
7.5.2 Radiomedix Major Business
7.5.3 Radiomedix Targeted Radiopharmaceuticals Product and Services
7.5.4 Radiomedix Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Radiomedix Recent Developments/Updates
7.5.6 Radiomedix Competitive Strengths & Weaknesses
7.6 Curium Pharma
7.6.1 Curium Pharma Details
7.6.2 Curium Pharma Major Business
7.6.3 Curium Pharma Targeted Radiopharmaceuticals Product and Services
7.6.4 Curium Pharma Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Curium Pharma Recent Developments/Updates
7.6.6 Curium Pharma Competitive Strengths & Weaknesses
7.7 Clarity Pharmaceuticals
7.7.1 Clarity Pharmaceuticals Details
7.7.2 Clarity Pharmaceuticals Major Business
7.7.3 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
7.7.4 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Clarity Pharmaceuticals Recent Developments/Updates
7.7.6 Clarity Pharmaceuticals Competitive Strengths & Weaknesses
7.8 ROTOP
7.8.1 ROTOP Details
7.8.2 ROTOP Major Business
7.8.3 ROTOP Targeted Radiopharmaceuticals Product and Services
7.8.4 ROTOP Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 ROTOP Recent Developments/Updates
7.8.6 ROTOP Competitive Strengths & Weaknesses
7.9 Ratio Therapeutics
7.9.1 Ratio Therapeutics Details
7.9.2 Ratio Therapeutics Major Business
7.9.3 Ratio Therapeutics Targeted Radiopharmaceuticals Product and Services
7.9.4 Ratio Therapeutics Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Ratio Therapeutics Recent Developments/Updates
7.9.6 Ratio Therapeutics Competitive Strengths & Weaknesses
7.10 Fusion Pharmaceuticals
7.10.1 Fusion Pharmaceuticals Details
7.10.2 Fusion Pharmaceuticals Major Business
7.10.3 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
7.10.4 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Fusion Pharmaceuticals Recent Developments/Updates
7.10.6 Fusion Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Perspective Therapeutics
7.11.1 Perspective Therapeutics Details
7.11.2 Perspective Therapeutics Major Business
7.11.3 Perspective Therapeutics Targeted Radiopharmaceuticals Product and Services
7.11.4 Perspective Therapeutics Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Perspective Therapeutics Recent Developments/Updates
7.11.6 Perspective Therapeutics Competitive Strengths & Weaknesses
7.12 RayzeBio
7.12.1 RayzeBio Details
7.12.2 RayzeBio Major Business
7.12.3 RayzeBio Targeted Radiopharmaceuticals Product and Services
7.12.4 RayzeBio Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 RayzeBio Recent Developments/Updates
7.12.6 RayzeBio Competitive Strengths & Weaknesses
7.13 Alpha-9 Theranostics
7.13.1 Alpha-9 Theranostics Details
7.13.2 Alpha-9 Theranostics Major Business
7.13.3 Alpha-9 Theranostics Targeted Radiopharmaceuticals Product and Services
7.13.4 Alpha-9 Theranostics Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Alpha-9 Theranostics Recent Developments/Updates
7.13.6 Alpha-9 Theranostics Competitive Strengths & Weaknesses
7.14 Radiopharm Theranostics
7.14.1 Radiopharm Theranostics Details
7.14.2 Radiopharm Theranostics Major Business
7.14.3 Radiopharm Theranostics Targeted Radiopharmaceuticals Product and Services
7.14.4 Radiopharm Theranostics Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Radiopharm Theranostics Recent Developments/Updates
7.14.6 Radiopharm Theranostics Competitive Strengths & Weaknesses
7.15 Telix Pharmaceuticals
7.15.1 Telix Pharmaceuticals Details
7.15.2 Telix Pharmaceuticals Major Business
7.15.3 Telix Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
7.15.4 Telix Pharmaceuticals Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Telix Pharmaceuticals Recent Developments/Updates
7.15.6 Telix Pharmaceuticals Competitive Strengths & Weaknesses
7.16 Ariceum Therapeutics
7.16.1 Ariceum Therapeutics Details
7.16.2 Ariceum Therapeutics Major Business
7.16.3 Ariceum Therapeutics Targeted Radiopharmaceuticals Product and Services
7.16.4 Ariceum Therapeutics Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Ariceum Therapeutics Recent Developments/Updates
7.16.6 Ariceum Therapeutics Competitive Strengths & Weaknesses
7.17 Aktis Oncology
7.17.1 Aktis Oncology Details
7.17.2 Aktis Oncology Major Business
7.17.3 Aktis Oncology Targeted Radiopharmaceuticals Product and Services
7.17.4 Aktis Oncology Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Aktis Oncology Recent Developments/Updates
7.17.6 Aktis Oncology Competitive Strengths & Weaknesses
7.18 Navidea Biopharmaceuticals
7.18.1 Navidea Biopharmaceuticals Details
7.18.2 Navidea Biopharmaceuticals Major Business
7.18.3 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product and Services
7.18.4 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Navidea Biopharmaceuticals Recent Developments/Updates
7.18.6 Navidea Biopharmaceuticals Competitive Strengths & Weaknesses
7.19 Nucleus RadioPharma
7.19.1 Nucleus RadioPharma Details
7.19.2 Nucleus RadioPharma Major Business
7.19.3 Nucleus RadioPharma Targeted Radiopharmaceuticals Product and Services
7.19.4 Nucleus RadioPharma Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Nucleus RadioPharma Recent Developments/Updates
7.19.6 Nucleus RadioPharma Competitive Strengths & Weaknesses
7.20 SmartNuclide Biopharma
7.20.1 SmartNuclide Biopharma Details
7.20.2 SmartNuclide Biopharma Major Business
7.20.3 SmartNuclide Biopharma Targeted Radiopharmaceuticals Product and Services
7.20.4 SmartNuclide Biopharma Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 SmartNuclide Biopharma Recent Developments/Updates
7.20.6 SmartNuclide Biopharma Competitive Strengths & Weaknesses
7.21 TetraKit Technologies
7.21.1 TetraKit Technologies Details
7.21.2 TetraKit Technologies Major Business
7.21.3 TetraKit Technologies Targeted Radiopharmaceuticals Product and Services
7.21.4 TetraKit Technologies Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 TetraKit Technologies Recent Developments/Updates
7.21.6 TetraKit Technologies Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Targeted Radiopharmaceuticals Industry Chain
8.2 Targeted Radiopharmaceuticals Upstream Analysis
8.2.1 Targeted Radiopharmaceuticals Core Raw Materials
8.2.2 Main Manufacturers of Targeted Radiopharmaceuticals Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Targeted Radiopharmaceuticals Production Mode
8.6 Targeted Radiopharmaceuticals Procurement Model
8.7 Targeted Radiopharmaceuticals Industry Sales Model and Sales Channels
8.7.1 Targeted Radiopharmaceuticals Sales Model
8.7.2 Targeted Radiopharmaceuticals Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Targeted Radiopharmaceuticals Introduction
1.2 World Targeted Radiopharmaceuticals Supply & Forecast
1.2.1 World Targeted Radiopharmaceuticals Production Value (2018 & 2022 & 2029)
1.2.2 World Targeted Radiopharmaceuticals Production (2018-2029)
1.2.3 World Targeted Radiopharmaceuticals Pricing Trends (2018-2029)
1.3 World Targeted Radiopharmaceuticals Production by Region (Based on Production Site)
1.3.1 World Targeted Radiopharmaceuticals Production Value by Region (2018-2029)
1.3.2 World Targeted Radiopharmaceuticals Production by Region (2018-2029)
1.3.3 World Targeted Radiopharmaceuticals Average Price by Region (2018-2029)
1.3.4 North America Targeted Radiopharmaceuticals Production (2018-2029)
1.3.5 Europe Targeted Radiopharmaceuticals Production (2018-2029)
1.3.6 China Targeted Radiopharmaceuticals Production (2018-2029)
1.3.7 Japan Targeted Radiopharmaceuticals Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Targeted Radiopharmaceuticals Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Targeted Radiopharmaceuticals Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Targeted Radiopharmaceuticals Demand (2018-2029)
2.2 World Targeted Radiopharmaceuticals Consumption by Region
2.2.1 World Targeted Radiopharmaceuticals Consumption by Region (2018-2023)
2.2.2 World Targeted Radiopharmaceuticals Consumption Forecast by Region (2024-2029)
2.3 United States Targeted Radiopharmaceuticals Consumption (2018-2029)
2.4 China Targeted Radiopharmaceuticals Consumption (2018-2029)
2.5 Europe Targeted Radiopharmaceuticals Consumption (2018-2029)
2.6 Japan Targeted Radiopharmaceuticals Consumption (2018-2029)
2.7 South Korea Targeted Radiopharmaceuticals Consumption (2018-2029)
2.8 ASEAN Targeted Radiopharmaceuticals Consumption (2018-2029)
2.9 India Targeted Radiopharmaceuticals Consumption (2018-2029)
3 WORLD TARGETED RADIOPHARMACEUTICALS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Targeted Radiopharmaceuticals Production Value by Manufacturer (2018-2023)
3.2 World Targeted Radiopharmaceuticals Production by Manufacturer (2018-2023)
3.3 World Targeted Radiopharmaceuticals Average Price by Manufacturer (2018-2023)
3.4 Targeted Radiopharmaceuticals Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Targeted Radiopharmaceuticals Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Targeted Radiopharmaceuticals in 2022
3.5.3 Global Concentration Ratios (CR8) for Targeted Radiopharmaceuticals in 2022
3.6 Targeted Radiopharmaceuticals Market: Overall Company Footprint Analysis
3.6.1 Targeted Radiopharmaceuticals Market: Region Footprint
3.6.2 Targeted Radiopharmaceuticals Market: Company Product Type Footprint
3.6.3 Targeted Radiopharmaceuticals Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Targeted Radiopharmaceuticals Production Value Comparison
4.1.1 United States VS China: Targeted Radiopharmaceuticals Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Targeted Radiopharmaceuticals Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Targeted Radiopharmaceuticals Production Comparison
4.2.1 United States VS China: Targeted Radiopharmaceuticals Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Targeted Radiopharmaceuticals Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Targeted Radiopharmaceuticals Consumption Comparison
4.3.1 United States VS China: Targeted Radiopharmaceuticals Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Targeted Radiopharmaceuticals Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Targeted Radiopharmaceuticals Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Targeted Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Targeted Radiopharmaceuticals Production Value (2018-2023)
4.4.3 United States Based Manufacturers Targeted Radiopharmaceuticals Production (2018-2023)
4.5 China Based Targeted Radiopharmaceuticals Manufacturers and Market Share
4.5.1 China Based Targeted Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Targeted Radiopharmaceuticals Production Value (2018-2023)
4.5.3 China Based Manufacturers Targeted Radiopharmaceuticals Production (2018-2023)
4.6 Rest of World Based Targeted Radiopharmaceuticals Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Targeted Radiopharmaceuticals Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Targeted Radiopharmaceuticals Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Targeted Radiopharmaceuticals Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Targeted Radiopharmaceuticals Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Targeted Therapeutic Radiopharmaceuticals
5.2.2 Targeted Diagnostic Radiopharmaceuticals
5.3 Market Segment by Type
5.3.1 World Targeted Radiopharmaceuticals Production by Type (2018-2029)
5.3.2 World Targeted Radiopharmaceuticals Production Value by Type (2018-2029)
5.3.3 World Targeted Radiopharmaceuticals Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Targeted Radiopharmaceuticals Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Targeted Therapy
6.2.2 Targeted Diagnosis
6.3 Market Segment by Application
6.3.1 World Targeted Radiopharmaceuticals Production by Application (2018-2029)
6.3.2 World Targeted Radiopharmaceuticals Production Value by Application (2018-2029)
6.3.3 World Targeted Radiopharmaceuticals Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Targeted Radiopharmaceuticals Product and Services
7.1.4 Novartis Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Bayer
7.2.1 Bayer Details
7.2.2 Bayer Major Business
7.2.3 Bayer Targeted Radiopharmaceuticals Product and Services
7.2.4 Bayer Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bayer Recent Developments/Updates
7.2.6 Bayer Competitive Strengths & Weaknesses
7.3 Lantheus
7.3.1 Lantheus Details
7.3.2 Lantheus Major Business
7.3.3 Lantheus Targeted Radiopharmaceuticals Product and Services
7.3.4 Lantheus Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Lantheus Recent Developments/Updates
7.3.6 Lantheus Competitive Strengths & Weaknesses
7.4 Institute for Radioelements (IRE)
7.4.1 Institute for Radioelements (IRE) Details
7.4.2 Institute for Radioelements (IRE) Major Business
7.4.3 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product and Services
7.4.4 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Institute for Radioelements (IRE) Recent Developments/Updates
7.4.6 Institute for Radioelements (IRE) Competitive Strengths & Weaknesses
7.5 Radiomedix
7.5.1 Radiomedix Details
7.5.2 Radiomedix Major Business
7.5.3 Radiomedix Targeted Radiopharmaceuticals Product and Services
7.5.4 Radiomedix Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Radiomedix Recent Developments/Updates
7.5.6 Radiomedix Competitive Strengths & Weaknesses
7.6 Curium Pharma
7.6.1 Curium Pharma Details
7.6.2 Curium Pharma Major Business
7.6.3 Curium Pharma Targeted Radiopharmaceuticals Product and Services
7.6.4 Curium Pharma Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Curium Pharma Recent Developments/Updates
7.6.6 Curium Pharma Competitive Strengths & Weaknesses
7.7 Clarity Pharmaceuticals
7.7.1 Clarity Pharmaceuticals Details
7.7.2 Clarity Pharmaceuticals Major Business
7.7.3 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
7.7.4 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Clarity Pharmaceuticals Recent Developments/Updates
7.7.6 Clarity Pharmaceuticals Competitive Strengths & Weaknesses
7.8 ROTOP
7.8.1 ROTOP Details
7.8.2 ROTOP Major Business
7.8.3 ROTOP Targeted Radiopharmaceuticals Product and Services
7.8.4 ROTOP Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 ROTOP Recent Developments/Updates
7.8.6 ROTOP Competitive Strengths & Weaknesses
7.9 Ratio Therapeutics
7.9.1 Ratio Therapeutics Details
7.9.2 Ratio Therapeutics Major Business
7.9.3 Ratio Therapeutics Targeted Radiopharmaceuticals Product and Services
7.9.4 Ratio Therapeutics Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Ratio Therapeutics Recent Developments/Updates
7.9.6 Ratio Therapeutics Competitive Strengths & Weaknesses
7.10 Fusion Pharmaceuticals
7.10.1 Fusion Pharmaceuticals Details
7.10.2 Fusion Pharmaceuticals Major Business
7.10.3 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
7.10.4 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Fusion Pharmaceuticals Recent Developments/Updates
7.10.6 Fusion Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Perspective Therapeutics
7.11.1 Perspective Therapeutics Details
7.11.2 Perspective Therapeutics Major Business
7.11.3 Perspective Therapeutics Targeted Radiopharmaceuticals Product and Services
7.11.4 Perspective Therapeutics Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Perspective Therapeutics Recent Developments/Updates
7.11.6 Perspective Therapeutics Competitive Strengths & Weaknesses
7.12 RayzeBio
7.12.1 RayzeBio Details
7.12.2 RayzeBio Major Business
7.12.3 RayzeBio Targeted Radiopharmaceuticals Product and Services
7.12.4 RayzeBio Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 RayzeBio Recent Developments/Updates
7.12.6 RayzeBio Competitive Strengths & Weaknesses
7.13 Alpha-9 Theranostics
7.13.1 Alpha-9 Theranostics Details
7.13.2 Alpha-9 Theranostics Major Business
7.13.3 Alpha-9 Theranostics Targeted Radiopharmaceuticals Product and Services
7.13.4 Alpha-9 Theranostics Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Alpha-9 Theranostics Recent Developments/Updates
7.13.6 Alpha-9 Theranostics Competitive Strengths & Weaknesses
7.14 Radiopharm Theranostics
7.14.1 Radiopharm Theranostics Details
7.14.2 Radiopharm Theranostics Major Business
7.14.3 Radiopharm Theranostics Targeted Radiopharmaceuticals Product and Services
7.14.4 Radiopharm Theranostics Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Radiopharm Theranostics Recent Developments/Updates
7.14.6 Radiopharm Theranostics Competitive Strengths & Weaknesses
7.15 Telix Pharmaceuticals
7.15.1 Telix Pharmaceuticals Details
7.15.2 Telix Pharmaceuticals Major Business
7.15.3 Telix Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
7.15.4 Telix Pharmaceuticals Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Telix Pharmaceuticals Recent Developments/Updates
7.15.6 Telix Pharmaceuticals Competitive Strengths & Weaknesses
7.16 Ariceum Therapeutics
7.16.1 Ariceum Therapeutics Details
7.16.2 Ariceum Therapeutics Major Business
7.16.3 Ariceum Therapeutics Targeted Radiopharmaceuticals Product and Services
7.16.4 Ariceum Therapeutics Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Ariceum Therapeutics Recent Developments/Updates
7.16.6 Ariceum Therapeutics Competitive Strengths & Weaknesses
7.17 Aktis Oncology
7.17.1 Aktis Oncology Details
7.17.2 Aktis Oncology Major Business
7.17.3 Aktis Oncology Targeted Radiopharmaceuticals Product and Services
7.17.4 Aktis Oncology Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Aktis Oncology Recent Developments/Updates
7.17.6 Aktis Oncology Competitive Strengths & Weaknesses
7.18 Navidea Biopharmaceuticals
7.18.1 Navidea Biopharmaceuticals Details
7.18.2 Navidea Biopharmaceuticals Major Business
7.18.3 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product and Services
7.18.4 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Navidea Biopharmaceuticals Recent Developments/Updates
7.18.6 Navidea Biopharmaceuticals Competitive Strengths & Weaknesses
7.19 Nucleus RadioPharma
7.19.1 Nucleus RadioPharma Details
7.19.2 Nucleus RadioPharma Major Business
7.19.3 Nucleus RadioPharma Targeted Radiopharmaceuticals Product and Services
7.19.4 Nucleus RadioPharma Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Nucleus RadioPharma Recent Developments/Updates
7.19.6 Nucleus RadioPharma Competitive Strengths & Weaknesses
7.20 SmartNuclide Biopharma
7.20.1 SmartNuclide Biopharma Details
7.20.2 SmartNuclide Biopharma Major Business
7.20.3 SmartNuclide Biopharma Targeted Radiopharmaceuticals Product and Services
7.20.4 SmartNuclide Biopharma Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 SmartNuclide Biopharma Recent Developments/Updates
7.20.6 SmartNuclide Biopharma Competitive Strengths & Weaknesses
7.21 TetraKit Technologies
7.21.1 TetraKit Technologies Details
7.21.2 TetraKit Technologies Major Business
7.21.3 TetraKit Technologies Targeted Radiopharmaceuticals Product and Services
7.21.4 TetraKit Technologies Targeted Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 TetraKit Technologies Recent Developments/Updates
7.21.6 TetraKit Technologies Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Targeted Radiopharmaceuticals Industry Chain
8.2 Targeted Radiopharmaceuticals Upstream Analysis
8.2.1 Targeted Radiopharmaceuticals Core Raw Materials
8.2.2 Main Manufacturers of Targeted Radiopharmaceuticals Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Targeted Radiopharmaceuticals Production Mode
8.6 Targeted Radiopharmaceuticals Procurement Model
8.7 Targeted Radiopharmaceuticals Industry Sales Model and Sales Channels
8.7.1 Targeted Radiopharmaceuticals Sales Model
8.7.2 Targeted Radiopharmaceuticals Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Targeted Radiopharmaceuticals Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Targeted Radiopharmaceuticals Production Value by Region (2018-2023) & (USD Million)
Table 3. World Targeted Radiopharmaceuticals Production Value by Region (2024-2029) & (USD Million)
Table 4. World Targeted Radiopharmaceuticals Production Value Market Share by Region (2018-2023)
Table 5. World Targeted Radiopharmaceuticals Production Value Market Share by Region (2024-2029)
Table 6. World Targeted Radiopharmaceuticals Production by Region (2018-2023) & (K Units)
Table 7. World Targeted Radiopharmaceuticals Production by Region (2024-2029) & (K Units)
Table 8. World Targeted Radiopharmaceuticals Production Market Share by Region (2018-2023)
Table 9. World Targeted Radiopharmaceuticals Production Market Share by Region (2024-2029)
Table 10. World Targeted Radiopharmaceuticals Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Targeted Radiopharmaceuticals Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Targeted Radiopharmaceuticals Major Market Trends
Table 13. World Targeted Radiopharmaceuticals Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Targeted Radiopharmaceuticals Consumption by Region (2018-2023) & (K Units)
Table 15. World Targeted Radiopharmaceuticals Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Targeted Radiopharmaceuticals Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Targeted Radiopharmaceuticals Producers in 2022
Table 18. World Targeted Radiopharmaceuticals Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Targeted Radiopharmaceuticals Producers in 2022
Table 20. World Targeted Radiopharmaceuticals Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Targeted Radiopharmaceuticals Company Evaluation Quadrant
Table 22. World Targeted Radiopharmaceuticals Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Targeted Radiopharmaceuticals Production Site of Key Manufacturer
Table 24. Targeted Radiopharmaceuticals Market: Company Product Type Footprint
Table 25. Targeted Radiopharmaceuticals Market: Company Product Application Footprint
Table 26. Targeted Radiopharmaceuticals Competitive Factors
Table 27. Targeted Radiopharmaceuticals New Entrant and Capacity Expansion Plans
Table 28. Targeted Radiopharmaceuticals Mergers & Acquisitions Activity
Table 29. United States VS China Targeted Radiopharmaceuticals Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Targeted Radiopharmaceuticals Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Targeted Radiopharmaceuticals Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Targeted Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Targeted Radiopharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Targeted Radiopharmaceuticals Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Targeted Radiopharmaceuticals Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Targeted Radiopharmaceuticals Production Market Share (2018-2023)
Table 37. China Based Targeted Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Targeted Radiopharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Targeted Radiopharmaceuticals Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Targeted Radiopharmaceuticals Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Targeted Radiopharmaceuticals Production Market Share (2018-2023)
Table 42. Rest of World Based Targeted Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Targeted Radiopharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Targeted Radiopharmaceuticals Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Targeted Radiopharmaceuticals Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Targeted Radiopharmaceuticals Production Market Share (2018-2023)
Table 47. World Targeted Radiopharmaceuticals Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Targeted Radiopharmaceuticals Production by Type (2018-2023) & (K Units)
Table 49. World Targeted Radiopharmaceuticals Production by Type (2024-2029) & (K Units)
Table 50. World Targeted Radiopharmaceuticals Production Value by Type (2018-2023) & (USD Million)
Table 51. World Targeted Radiopharmaceuticals Production Value by Type (2024-2029) & (USD Million)
Table 52. World Targeted Radiopharmaceuticals Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Targeted Radiopharmaceuticals Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Targeted Radiopharmaceuticals Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Targeted Radiopharmaceuticals Production by Application (2018-2023) & (K Units)
Table 56. World Targeted Radiopharmaceuticals Production by Application (2024-2029) & (K Units)
Table 57. World Targeted Radiopharmaceuticals Production Value by Application (2018-2023) & (USD Million)
Table 58. World Targeted Radiopharmaceuticals Production Value by Application (2024-2029) & (USD Million)
Table 59. World Targeted Radiopharmaceuticals Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Targeted Radiopharmaceuticals Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Targeted Radiopharmaceuticals Product and Services
Table 64. Novartis Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Major Business
Table 69. Bayer Targeted Radiopharmaceuticals Product and Services
Table 70. Bayer Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bayer Recent Developments/Updates
Table 72. Bayer Competitive Strengths & Weaknesses
Table 73. Lantheus Basic Information, Manufacturing Base and Competitors
Table 74. Lantheus Major Business
Table 75. Lantheus Targeted Radiopharmaceuticals Product and Services
Table 76. Lantheus Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Lantheus Recent Developments/Updates
Table 78. Lantheus Competitive Strengths & Weaknesses
Table 79. Institute for Radioelements (IRE) Basic Information, Manufacturing Base and Competitors
Table 80. Institute for Radioelements (IRE) Major Business
Table 81. Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product and Services
Table 82. Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Institute for Radioelements (IRE) Recent Developments/Updates
Table 84. Institute for Radioelements (IRE) Competitive Strengths & Weaknesses
Table 85. Radiomedix Basic Information, Manufacturing Base and Competitors
Table 86. Radiomedix Major Business
Table 87. Radiomedix Targeted Radiopharmaceuticals Product and Services
Table 88. Radiomedix Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Radiomedix Recent Developments/Updates
Table 90. Radiomedix Competitive Strengths & Weaknesses
Table 91. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Curium Pharma Major Business
Table 93. Curium Pharma Targeted Radiopharmaceuticals Product and Services
Table 94. Curium Pharma Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Curium Pharma Recent Developments/Updates
Table 96. Curium Pharma Competitive Strengths & Weaknesses
Table 97. Clarity Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 98. Clarity Pharmaceuticals Major Business
Table 99. Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
Table 100. Clarity Pharmaceuticals Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Clarity Pharmaceuticals Recent Developments/Updates
Table 102. Clarity Pharmaceuticals Competitive Strengths & Weaknesses
Table 103. ROTOP Basic Information, Manufacturing Base and Competitors
Table 104. ROTOP Major Business
Table 105. ROTOP Targeted Radiopharmaceuticals Product and Services
Table 106. ROTOP Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. ROTOP Recent Developments/Updates
Table 108. ROTOP Competitive Strengths & Weaknesses
Table 109. Ratio Therapeutics Basic Information, Manufacturing Base and Competitors
Table 110. Ratio Therapeutics Major Business
Table 111. Ratio Therapeutics Targeted Radiopharmaceuticals Product and Services
Table 112. Ratio Therapeutics Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Ratio Therapeutics Recent Developments/Updates
Table 114. Ratio Therapeutics Competitive Strengths & Weaknesses
Table 115. Fusion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. Fusion Pharmaceuticals Major Business
Table 117. Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
Table 118. Fusion Pharmaceuticals Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Fusion Pharmaceuticals Recent Developments/Updates
Table 120. Fusion Pharmaceuticals Competitive Strengths & Weaknesses
Table 121. Perspective Therapeutics Basic Information, Manufacturing Base and Competitors
Table 122. Perspective Therapeutics Major Business
Table 123. Perspective Therapeutics Targeted Radiopharmaceuticals Product and Services
Table 124. Perspective Therapeutics Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Perspective Therapeutics Recent Developments/Updates
Table 126. Perspective Therapeutics Competitive Strengths & Weaknesses
Table 127. RayzeBio Basic Information, Manufacturing Base and Competitors
Table 128. RayzeBio Major Business
Table 129. RayzeBio Targeted Radiopharmaceuticals Product and Services
Table 130. RayzeBio Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. RayzeBio Recent Developments/Updates
Table 132. RayzeBio Competitive Strengths & Weaknesses
Table 133. Alpha-9 Theranostics Basic Information, Manufacturing Base and Competitors
Table 134. Alpha-9 Theranostics Major Business
Table 135. Alpha-9 Theranostics Targeted Radiopharmaceuticals Product and Services
Table 136. Alpha-9 Theranostics Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Alpha-9 Theranostics Recent Developments/Updates
Table 138. Alpha-9 Theranostics Competitive Strengths & Weaknesses
Table 139. Radiopharm Theranostics Basic Information, Manufacturing Base and Competitors
Table 140. Radiopharm Theranostics Major Business
Table 141. Radiopharm Theranostics Targeted Radiopharmaceuticals Product and Services
Table 142. Radiopharm Theranostics Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Radiopharm Theranostics Recent Developments/Updates
Table 144. Radiopharm Theranostics Competitive Strengths & Weaknesses
Table 145. Telix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 146. Telix Pharmaceuticals Major Business
Table 147. Telix Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
Table 148. Telix Pharmaceuticals Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Telix Pharmaceuticals Recent Developments/Updates
Table 150. Telix Pharmaceuticals Competitive Strengths & Weaknesses
Table 151. Ariceum Therapeutics Basic Information, Manufacturing Base and Competitors
Table 152. Ariceum Therapeutics Major Business
Table 153. Ariceum Therapeutics Targeted Radiopharmaceuticals Product and Services
Table 154. Ariceum Therapeutics Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Ariceum Therapeutics Recent Developments/Updates
Table 156. Ariceum Therapeutics Competitive Strengths & Weaknesses
Table 157. Aktis Oncology Basic Information, Manufacturing Base and Competitors
Table 158. Aktis Oncology Major Business
Table 159. Aktis Oncology Targeted Radiopharmaceuticals Product and Services
Table 160. Aktis Oncology Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Aktis Oncology Recent Developments/Updates
Table 162. Aktis Oncology Competitive Strengths & Weaknesses
Table 163. Navidea Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 164. Navidea Biopharmaceuticals Major Business
Table 165. Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product and Services
Table 166. Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Navidea Biopharmaceuticals Recent Developments/Updates
Table 168. Navidea Biopharmaceuticals Competitive Strengths & Weaknesses
Table 169. Nucleus RadioPharma Basic Information, Manufacturing Base and Competitors
Table 170. Nucleus RadioPharma Major Business
Table 171. Nucleus RadioPharma Targeted Radiopharmaceuticals Product and Services
Table 172. Nucleus RadioPharma Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Nucleus RadioPharma Recent Developments/Updates
Table 174. Nucleus RadioPharma Competitive Strengths & Weaknesses
Table 175. SmartNuclide Biopharma Basic Information, Manufacturing Base and Competitors
Table 176. SmartNuclide Biopharma Major Business
Table 177. SmartNuclide Biopharma Targeted Radiopharmaceuticals Product and Services
Table 178. SmartNuclide Biopharma Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. SmartNuclide Biopharma Recent Developments/Updates
Table 180. TetraKit Technologies Basic Information, Manufacturing Base and Competitors
Table 181. TetraKit Technologies Major Business
Table 182. TetraKit Technologies Targeted Radiopharmaceuticals Product and Services
Table 183. TetraKit Technologies Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 184. Global Key Players of Targeted Radiopharmaceuticals Upstream (Raw Materials)
Table 185. Targeted Radiopharmaceuticals Typical Customers
Table 186. Targeted Radiopharmaceuticals Typical Distributors
List of Figure
Figure 1. Targeted Radiopharmaceuticals Picture
Figure 2. World Targeted Radiopharmaceuticals Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Targeted Radiopharmaceuticals Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Targeted Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 5. World Targeted Radiopharmaceuticals Average Price (2018-2029) & (US$/Unit)
Figure 6. World Targeted Radiopharmaceuticals Production Value Market Share by Region (2018-2029)
Figure 7. World Targeted Radiopharmaceuticals Production Market Share by Region (2018-2029)
Figure 8. North America Targeted Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 9. Europe Targeted Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 10. China Targeted Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 11. Japan Targeted Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 12. Targeted Radiopharmaceuticals Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Targeted Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 15. World Targeted Radiopharmaceuticals Consumption Market Share by Region (2018-2029)
Figure 16. United States Targeted Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 17. China Targeted Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 18. Europe Targeted Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 19. Japan Targeted Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 20. South Korea Targeted Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Targeted Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 22. India Targeted Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Targeted Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Targeted Radiopharmaceuticals Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Targeted Radiopharmaceuticals Markets in 2022
Figure 26. United States VS China: Targeted Radiopharmaceuticals Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Targeted Radiopharmaceuticals Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Targeted Radiopharmaceuticals Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Targeted Radiopharmaceuticals Production Market Share 2022
Figure 30. China Based Manufacturers Targeted Radiopharmaceuticals Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Targeted Radiopharmaceuticals Production Market Share 2022
Figure 32. World Targeted Radiopharmaceuticals Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Targeted Radiopharmaceuticals Production Value Market Share by Type in 2022
Figure 34. Targeted Therapeutic Radiopharmaceuticals
Figure 35. Targeted Diagnostic Radiopharmaceuticals
Figure 36. World Targeted Radiopharmaceuticals Production Market Share by Type (2018-2029)
Figure 37. World Targeted Radiopharmaceuticals Production Value Market Share by Type (2018-2029)
Figure 38. World Targeted Radiopharmaceuticals Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Targeted Radiopharmaceuticals Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Targeted Radiopharmaceuticals Production Value Market Share by Application in 2022
Figure 41. Targeted Therapy
Figure 42. Targeted Diagnosis
Figure 43. World Targeted Radiopharmaceuticals Production Market Share by Application (2018-2029)
Figure 44. World Targeted Radiopharmaceuticals Production Value Market Share by Application (2018-2029)
Figure 45. World Targeted Radiopharmaceuticals Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Targeted Radiopharmaceuticals Industry Chain
Figure 47. Targeted Radiopharmaceuticals Procurement Model
Figure 48. Targeted Radiopharmaceuticals Sales Model
Figure 49. Targeted Radiopharmaceuticals Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Table 1. World Targeted Radiopharmaceuticals Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Targeted Radiopharmaceuticals Production Value by Region (2018-2023) & (USD Million)
Table 3. World Targeted Radiopharmaceuticals Production Value by Region (2024-2029) & (USD Million)
Table 4. World Targeted Radiopharmaceuticals Production Value Market Share by Region (2018-2023)
Table 5. World Targeted Radiopharmaceuticals Production Value Market Share by Region (2024-2029)
Table 6. World Targeted Radiopharmaceuticals Production by Region (2018-2023) & (K Units)
Table 7. World Targeted Radiopharmaceuticals Production by Region (2024-2029) & (K Units)
Table 8. World Targeted Radiopharmaceuticals Production Market Share by Region (2018-2023)
Table 9. World Targeted Radiopharmaceuticals Production Market Share by Region (2024-2029)
Table 10. World Targeted Radiopharmaceuticals Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Targeted Radiopharmaceuticals Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Targeted Radiopharmaceuticals Major Market Trends
Table 13. World Targeted Radiopharmaceuticals Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Targeted Radiopharmaceuticals Consumption by Region (2018-2023) & (K Units)
Table 15. World Targeted Radiopharmaceuticals Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Targeted Radiopharmaceuticals Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Targeted Radiopharmaceuticals Producers in 2022
Table 18. World Targeted Radiopharmaceuticals Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Targeted Radiopharmaceuticals Producers in 2022
Table 20. World Targeted Radiopharmaceuticals Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Targeted Radiopharmaceuticals Company Evaluation Quadrant
Table 22. World Targeted Radiopharmaceuticals Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Targeted Radiopharmaceuticals Production Site of Key Manufacturer
Table 24. Targeted Radiopharmaceuticals Market: Company Product Type Footprint
Table 25. Targeted Radiopharmaceuticals Market: Company Product Application Footprint
Table 26. Targeted Radiopharmaceuticals Competitive Factors
Table 27. Targeted Radiopharmaceuticals New Entrant and Capacity Expansion Plans
Table 28. Targeted Radiopharmaceuticals Mergers & Acquisitions Activity
Table 29. United States VS China Targeted Radiopharmaceuticals Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Targeted Radiopharmaceuticals Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Targeted Radiopharmaceuticals Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Targeted Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Targeted Radiopharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Targeted Radiopharmaceuticals Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Targeted Radiopharmaceuticals Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Targeted Radiopharmaceuticals Production Market Share (2018-2023)
Table 37. China Based Targeted Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Targeted Radiopharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Targeted Radiopharmaceuticals Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Targeted Radiopharmaceuticals Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Targeted Radiopharmaceuticals Production Market Share (2018-2023)
Table 42. Rest of World Based Targeted Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Targeted Radiopharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Targeted Radiopharmaceuticals Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Targeted Radiopharmaceuticals Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Targeted Radiopharmaceuticals Production Market Share (2018-2023)
Table 47. World Targeted Radiopharmaceuticals Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Targeted Radiopharmaceuticals Production by Type (2018-2023) & (K Units)
Table 49. World Targeted Radiopharmaceuticals Production by Type (2024-2029) & (K Units)
Table 50. World Targeted Radiopharmaceuticals Production Value by Type (2018-2023) & (USD Million)
Table 51. World Targeted Radiopharmaceuticals Production Value by Type (2024-2029) & (USD Million)
Table 52. World Targeted Radiopharmaceuticals Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Targeted Radiopharmaceuticals Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Targeted Radiopharmaceuticals Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Targeted Radiopharmaceuticals Production by Application (2018-2023) & (K Units)
Table 56. World Targeted Radiopharmaceuticals Production by Application (2024-2029) & (K Units)
Table 57. World Targeted Radiopharmaceuticals Production Value by Application (2018-2023) & (USD Million)
Table 58. World Targeted Radiopharmaceuticals Production Value by Application (2024-2029) & (USD Million)
Table 59. World Targeted Radiopharmaceuticals Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Targeted Radiopharmaceuticals Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Targeted Radiopharmaceuticals Product and Services
Table 64. Novartis Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Major Business
Table 69. Bayer Targeted Radiopharmaceuticals Product and Services
Table 70. Bayer Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bayer Recent Developments/Updates
Table 72. Bayer Competitive Strengths & Weaknesses
Table 73. Lantheus Basic Information, Manufacturing Base and Competitors
Table 74. Lantheus Major Business
Table 75. Lantheus Targeted Radiopharmaceuticals Product and Services
Table 76. Lantheus Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Lantheus Recent Developments/Updates
Table 78. Lantheus Competitive Strengths & Weaknesses
Table 79. Institute for Radioelements (IRE) Basic Information, Manufacturing Base and Competitors
Table 80. Institute for Radioelements (IRE) Major Business
Table 81. Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product and Services
Table 82. Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Institute for Radioelements (IRE) Recent Developments/Updates
Table 84. Institute for Radioelements (IRE) Competitive Strengths & Weaknesses
Table 85. Radiomedix Basic Information, Manufacturing Base and Competitors
Table 86. Radiomedix Major Business
Table 87. Radiomedix Targeted Radiopharmaceuticals Product and Services
Table 88. Radiomedix Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Radiomedix Recent Developments/Updates
Table 90. Radiomedix Competitive Strengths & Weaknesses
Table 91. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Curium Pharma Major Business
Table 93. Curium Pharma Targeted Radiopharmaceuticals Product and Services
Table 94. Curium Pharma Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Curium Pharma Recent Developments/Updates
Table 96. Curium Pharma Competitive Strengths & Weaknesses
Table 97. Clarity Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 98. Clarity Pharmaceuticals Major Business
Table 99. Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
Table 100. Clarity Pharmaceuticals Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Clarity Pharmaceuticals Recent Developments/Updates
Table 102. Clarity Pharmaceuticals Competitive Strengths & Weaknesses
Table 103. ROTOP Basic Information, Manufacturing Base and Competitors
Table 104. ROTOP Major Business
Table 105. ROTOP Targeted Radiopharmaceuticals Product and Services
Table 106. ROTOP Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. ROTOP Recent Developments/Updates
Table 108. ROTOP Competitive Strengths & Weaknesses
Table 109. Ratio Therapeutics Basic Information, Manufacturing Base and Competitors
Table 110. Ratio Therapeutics Major Business
Table 111. Ratio Therapeutics Targeted Radiopharmaceuticals Product and Services
Table 112. Ratio Therapeutics Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Ratio Therapeutics Recent Developments/Updates
Table 114. Ratio Therapeutics Competitive Strengths & Weaknesses
Table 115. Fusion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. Fusion Pharmaceuticals Major Business
Table 117. Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
Table 118. Fusion Pharmaceuticals Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Fusion Pharmaceuticals Recent Developments/Updates
Table 120. Fusion Pharmaceuticals Competitive Strengths & Weaknesses
Table 121. Perspective Therapeutics Basic Information, Manufacturing Base and Competitors
Table 122. Perspective Therapeutics Major Business
Table 123. Perspective Therapeutics Targeted Radiopharmaceuticals Product and Services
Table 124. Perspective Therapeutics Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Perspective Therapeutics Recent Developments/Updates
Table 126. Perspective Therapeutics Competitive Strengths & Weaknesses
Table 127. RayzeBio Basic Information, Manufacturing Base and Competitors
Table 128. RayzeBio Major Business
Table 129. RayzeBio Targeted Radiopharmaceuticals Product and Services
Table 130. RayzeBio Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. RayzeBio Recent Developments/Updates
Table 132. RayzeBio Competitive Strengths & Weaknesses
Table 133. Alpha-9 Theranostics Basic Information, Manufacturing Base and Competitors
Table 134. Alpha-9 Theranostics Major Business
Table 135. Alpha-9 Theranostics Targeted Radiopharmaceuticals Product and Services
Table 136. Alpha-9 Theranostics Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Alpha-9 Theranostics Recent Developments/Updates
Table 138. Alpha-9 Theranostics Competitive Strengths & Weaknesses
Table 139. Radiopharm Theranostics Basic Information, Manufacturing Base and Competitors
Table 140. Radiopharm Theranostics Major Business
Table 141. Radiopharm Theranostics Targeted Radiopharmaceuticals Product and Services
Table 142. Radiopharm Theranostics Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Radiopharm Theranostics Recent Developments/Updates
Table 144. Radiopharm Theranostics Competitive Strengths & Weaknesses
Table 145. Telix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 146. Telix Pharmaceuticals Major Business
Table 147. Telix Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
Table 148. Telix Pharmaceuticals Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Telix Pharmaceuticals Recent Developments/Updates
Table 150. Telix Pharmaceuticals Competitive Strengths & Weaknesses
Table 151. Ariceum Therapeutics Basic Information, Manufacturing Base and Competitors
Table 152. Ariceum Therapeutics Major Business
Table 153. Ariceum Therapeutics Targeted Radiopharmaceuticals Product and Services
Table 154. Ariceum Therapeutics Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Ariceum Therapeutics Recent Developments/Updates
Table 156. Ariceum Therapeutics Competitive Strengths & Weaknesses
Table 157. Aktis Oncology Basic Information, Manufacturing Base and Competitors
Table 158. Aktis Oncology Major Business
Table 159. Aktis Oncology Targeted Radiopharmaceuticals Product and Services
Table 160. Aktis Oncology Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Aktis Oncology Recent Developments/Updates
Table 162. Aktis Oncology Competitive Strengths & Weaknesses
Table 163. Navidea Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 164. Navidea Biopharmaceuticals Major Business
Table 165. Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product and Services
Table 166. Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Navidea Biopharmaceuticals Recent Developments/Updates
Table 168. Navidea Biopharmaceuticals Competitive Strengths & Weaknesses
Table 169. Nucleus RadioPharma Basic Information, Manufacturing Base and Competitors
Table 170. Nucleus RadioPharma Major Business
Table 171. Nucleus RadioPharma Targeted Radiopharmaceuticals Product and Services
Table 172. Nucleus RadioPharma Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Nucleus RadioPharma Recent Developments/Updates
Table 174. Nucleus RadioPharma Competitive Strengths & Weaknesses
Table 175. SmartNuclide Biopharma Basic Information, Manufacturing Base and Competitors
Table 176. SmartNuclide Biopharma Major Business
Table 177. SmartNuclide Biopharma Targeted Radiopharmaceuticals Product and Services
Table 178. SmartNuclide Biopharma Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. SmartNuclide Biopharma Recent Developments/Updates
Table 180. TetraKit Technologies Basic Information, Manufacturing Base and Competitors
Table 181. TetraKit Technologies Major Business
Table 182. TetraKit Technologies Targeted Radiopharmaceuticals Product and Services
Table 183. TetraKit Technologies Targeted Radiopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 184. Global Key Players of Targeted Radiopharmaceuticals Upstream (Raw Materials)
Table 185. Targeted Radiopharmaceuticals Typical Customers
Table 186. Targeted Radiopharmaceuticals Typical Distributors
List of Figure
Figure 1. Targeted Radiopharmaceuticals Picture
Figure 2. World Targeted Radiopharmaceuticals Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Targeted Radiopharmaceuticals Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Targeted Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 5. World Targeted Radiopharmaceuticals Average Price (2018-2029) & (US$/Unit)
Figure 6. World Targeted Radiopharmaceuticals Production Value Market Share by Region (2018-2029)
Figure 7. World Targeted Radiopharmaceuticals Production Market Share by Region (2018-2029)
Figure 8. North America Targeted Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 9. Europe Targeted Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 10. China Targeted Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 11. Japan Targeted Radiopharmaceuticals Production (2018-2029) & (K Units)
Figure 12. Targeted Radiopharmaceuticals Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Targeted Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 15. World Targeted Radiopharmaceuticals Consumption Market Share by Region (2018-2029)
Figure 16. United States Targeted Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 17. China Targeted Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 18. Europe Targeted Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 19. Japan Targeted Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 20. South Korea Targeted Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Targeted Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 22. India Targeted Radiopharmaceuticals Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Targeted Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Targeted Radiopharmaceuticals Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Targeted Radiopharmaceuticals Markets in 2022
Figure 26. United States VS China: Targeted Radiopharmaceuticals Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Targeted Radiopharmaceuticals Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Targeted Radiopharmaceuticals Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Targeted Radiopharmaceuticals Production Market Share 2022
Figure 30. China Based Manufacturers Targeted Radiopharmaceuticals Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Targeted Radiopharmaceuticals Production Market Share 2022
Figure 32. World Targeted Radiopharmaceuticals Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Targeted Radiopharmaceuticals Production Value Market Share by Type in 2022
Figure 34. Targeted Therapeutic Radiopharmaceuticals
Figure 35. Targeted Diagnostic Radiopharmaceuticals
Figure 36. World Targeted Radiopharmaceuticals Production Market Share by Type (2018-2029)
Figure 37. World Targeted Radiopharmaceuticals Production Value Market Share by Type (2018-2029)
Figure 38. World Targeted Radiopharmaceuticals Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Targeted Radiopharmaceuticals Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Targeted Radiopharmaceuticals Production Value Market Share by Application in 2022
Figure 41. Targeted Therapy
Figure 42. Targeted Diagnosis
Figure 43. World Targeted Radiopharmaceuticals Production Market Share by Application (2018-2029)
Figure 44. World Targeted Radiopharmaceuticals Production Value Market Share by Application (2018-2029)
Figure 45. World Targeted Radiopharmaceuticals Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Targeted Radiopharmaceuticals Industry Chain
Figure 47. Targeted Radiopharmaceuticals Procurement Model
Figure 48. Targeted Radiopharmaceuticals Sales Model
Figure 49. Targeted Radiopharmaceuticals Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
